Susan ALTSCHULLER - Chief Financial Officer at Cerevel Therapeutics Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
CERE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Susan ALTSCHULLER - trading volume in the past year for Cerevel Therapeutics Holdings, Inc.

Holdings reported by Susan ALTSCHULLER for Cerevel Therapeutics Holdings, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 81,065 $3.42 M $42.24 Jan 19, 2024 Direct Common Stock
Common Stock 16,913 $714 K $42.24 Dec 20, 2023 Direct
Stock Option (Right to Buy) 124,168 Jun 1, 2023 Direct Common Stock

Transactions reported by Susan ALTSCHULLER for Cerevel Therapeutics Holdings, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership